Tara Bancroft
Stock Analyst at TD Cowen
(2.63)
# 2,115
Out of 4,735 analysts
8
Total ratings
50%
Success rate
23.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $29.86 | +67.45% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $38.10 | +70.60% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $8.09 | +35.97% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $2.96 | +237.84% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $39.74 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $13.56 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $29.86
Upside: +67.45%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $38.10
Upside: +70.60%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $8.09
Upside: +35.97%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $2.96
Upside: +237.84%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $39.74
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $13.56
Upside: -